Addus HomeCare (ADUS) Competitors $114.86 -0.59 (-0.51%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$115.88 +1.02 (+0.88%) As of 10/3/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ADUS vs. GH, RDNT, BTSG, SHC, OPCH, WGS, PRVA, SGRY, HTFL, and CONShould you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Option Care Health (OPCH), GeneDx (WGS), Privia Health Group (PRVA), Surgery Partners (SGRY), Heartflow (HTFL), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Addus HomeCare vs. Its Competitors Guardant Health RadNet BrightSpring Health Services Sotera Health Option Care Health GeneDx Privia Health Group Surgery Partners Heartflow Concentra Group Holdings Parent Addus HomeCare (NASDAQ:ADUS) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Which has higher earnings and valuation, ADUS or GH? Addus HomeCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAddus HomeCare$1.15B1.83$73.60M$4.5325.36Guardant Health$739.02M10.60-$436.37M-$3.35-18.76 Is ADUS or GH more profitable? Addus HomeCare has a net margin of 6.51% compared to Guardant Health's net margin of -49.93%. Addus HomeCare's return on equity of 9.39% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Addus HomeCare6.51% 9.39% 6.86% Guardant Health -49.93%N/A -28.95% Which has more risk and volatility, ADUS or GH? Addus HomeCare has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.53, suggesting that its stock price is 53% more volatile than the S&P 500. Does the media favor ADUS or GH? In the previous week, Guardant Health had 5 more articles in the media than Addus HomeCare. MarketBeat recorded 9 mentions for Guardant Health and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.06 beat Guardant Health's score of 0.25 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 3 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Do institutionals and insiders hold more shares of ADUS or GH? 95.4% of Addus HomeCare shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 4.5% of Addus HomeCare shares are owned by company insiders. Comparatively, 6.1% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts rate ADUS or GH? Addus HomeCare currently has a consensus price target of $138.89, suggesting a potential upside of 20.92%. Guardant Health has a consensus price target of $65.75, suggesting a potential upside of 4.63%. Given Addus HomeCare's higher possible upside, research analysts clearly believe Addus HomeCare is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Addus HomeCare 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.91Guardant Health 1 Sell rating(s) 0 Hold rating(s) 22 Buy rating(s) 1 Strong Buy rating(s) 2.96 SummaryAddus HomeCare beats Guardant Health on 11 of the 17 factors compared between the two stocks. Get Addus HomeCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADUS vs. The Competition Export to ExcelMetricAddus HomeCareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.12B$4.22B$6.12B$10.55BDividend YieldN/A1.26%5.66%4.70%P/E Ratio25.3626.9386.9626.71Price / Sales1.83233.54569.72225.61Price / Cash21.3128.4726.3031.09Price / Book2.154.7112.536.57Net Income$73.60M$197.51M$3.30B$276.78M7 Day Performance-2.49%0.57%3.53%1.98%1 Month Performance1.45%2.85%6.77%9.13%1 Year Performance-9.06%26.34%70.60%31.60% Addus HomeCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADUSAddus HomeCare4.9626 of 5 stars$114.86-0.5%$138.89+20.9%-9.1%$2.12B$1.15B25.3649,703GHGuardant Health3.7214 of 5 stars$61.99+3.3%$65.25+5.3%+183.6%$7.49B$739.02M-18.502,021RDNTRadNet3.0787 of 5 stars$74.70-1.6%$76.80+2.8%+13.1%$5.84B$1.83B-373.4811,021Positive NewsBTSGBrightSpring Health Services2.762 of 5 stars$28.13+2.7%$27.10-3.7%+92.1%$4.85B$12.57B90.7435,000SHCSotera Health2.5298 of 5 stars$15.75-0.4%$16.00+1.6%+0.9%$4.49B$1.10B196.903,000OPCHOption Care Health4.8801 of 5 stars$27.54+0.9%$35.75+29.8%-5.7%$4.43B$5.00B22.038,088Positive NewsWGSGeneDx2.3076 of 5 stars$113.93-2.8%$104.13-8.6%+137.4%$3.37B$362.32M2,278.601,200Positive NewsPRVAPrivia Health Group3.4387 of 5 stars$24.42+1.9%$28.58+17.0%+37.0%$2.94B$1.74B222.021,140SGRYSurgery Partners3.1481 of 5 stars$21.91+0.3%$32.88+50.0%-32.1%$2.80B$3.11B-15.3215,000Positive NewsHTFLHeartflowN/A$34.50+4.4%$36.60+6.1%N/A$2.76B$148.54M0.00699CONConcentra Group Holdings Parent2.889 of 5 stars$20.79-0.2%$27.75+33.5%-0.8%$2.67B$1.90B17.4711,250 Related Companies and Tools Related Companies Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Option Care Health Alternatives GeneDx Alternatives Privia Health Group Alternatives Surgery Partners Alternatives Heartflow Alternatives Concentra Group Holdings Parent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADUS) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredThis soon could be the most precious company in AmericaCurrently, a brand-new, all-American factory outside San Antonio is becoming the most significant site in the ...True Market Insiders | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredChina’s New Gold Play Could Make your Income SoarChina's New Gold Move Could Pay You up to $1,152/month. China just announced plans to store other nations' ...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Addus HomeCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
